<DOC>
	<DOCNO>NCT00588406</DOCNO>
	<brief_summary>To determine whether add nebulized inhaled steroid standard care acutely ill ED patient refractory acute asthma help improve forced expiratory volume one second ( FEV1 ) decrease need hospitalization .</brief_summary>
	<brief_title>Study Budesonide Addition Standard Therapy Adult Asthmatics Emergency Room .</brief_title>
	<detailed_description>This randomize clinical trial study effect nebulized budesonide ( Pulmicort ) acutely ill adult present Emergency Department severe asthma . Budesonide inhale steroid FDA approve treatment pediatric chronic asthma . ED entry criterion include hyporesponsiveness nebulized beta-agonists FEV1 &lt; 50 % predict . The trial evaluate efficacy multiple dos nebulized budesonide adjunct highly regiment standardized treatment protocol ; standard care consist bronchodilator ( beta-agonists/anticholinergics ) , systemic steroid , intravenous magnesium sulfate ( FEV1 &lt; 25 % predict ) . The primary efficacy endpoint FEV1 4 hour administration study intervention . An additional safety efficacy endpoint take place 5 hour study intervention . The treatment couple protocol-defined assessment regimen , endpoint measure treatment ED disposition ( 5 hour study intervention ) .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>FEV1 &lt; 50 % predict bronchodilator therapy , age 1860 , present emergency department acute asthma chronic lung disease , &gt; 15 pack year smoke</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>acute , emergency department</keyword>
</DOC>